Cellvie Company

cellvie is pioneering Therapeutic Mitochondria Transfer, a novel treatment approach aimed at the cellular energy metabolism. The technology's first application will be in ischemia-reperfusion injury, specifically in kidney transplantation. But the aim is to develop a broad platform.
Industry: PharmTech
Headquarters: Matzingen / Switzerland
Founded Date: 2018
Employees Number: 1-10
Investors Number: 1
Total Funding: 5000000
Last Funding Date: 2021
Last Funding Type: Seed

Visit Website
Register and Claim Ownership